OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Optimizing these processes involves modifying various variables, including cell line selection, media formulation, and bioreactor settings. A key goal is to maximize antibody titer while lowering production expenses and